Ht-Logo-gigapixel-icon
Sunday, November 24, 2024
Canada’s Politics and Government News Source Since 1989
Sunday, November 24, 2024 | Latest Paper

Chrisoula Nikidis

Chrisoula Nikidis is vice-president, ethics, integrity and governance at Innovative Medicines Canada and industry co-chair of the APEC Biopharmaceutical Ethics Working Group.

Ethics week: Canada’s leadership something to be celebrated; stronger when we work together

Opinion | BY CHRISOULA NIKIDIS | April 4, 2017
Health Minister Jane Philpott, pictured March 29 at the Senate's Legal and Constitutional Affairs Committee, to talk about Bill C-37, the Controlled Drugs and Substances Act. The Hill Times photograph by Jake Wright
Opinion | BY CHRISOULA NIKIDIS | April 4, 2017
Opinion | BY CHRISOULA NIKIDIS | April 4, 2017
Health Minister Jane Philpott, pictured March 29 at the Senate's Legal and Constitutional Affairs Committee, to talk about Bill C-37, the Controlled Drugs and Substances Act. The Hill Times photograph by Jake Wright
Opinion | BY CHRISOULA NIKIDIS | April 4, 2017
Health Minister Jane Philpott, pictured March 29 at the Senate's Legal and Constitutional Affairs Committee, to talk about Bill C-37, the Controlled Drugs and Substances Act. The Hill Times photograph by Jake Wright
Opinion | BY CHRISOULA NIKIDIS | April 4, 2017
Opinion | BY CHRISOULA NIKIDIS | April 4, 2017
Health Minister Jane Philpott, pictured March 29 at the Senate's Legal and Constitutional Affairs Committee, to talk about Bill C-37, the Controlled Drugs and Substances Act. The Hill Times photograph by Jake Wright